Natco Pharma Limited-RE Peer Comparison
NATCO-RE · Healthcare · Current price ₹25.95
Peers tracked
11
Natco Pharma Limited-RE P/E
—
Sector
Healthcare
Natco Pharma Limited-RE vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| ANG Lifesciences India Ltd | — | -3.5x | 49 |
| Mangalam Drugs And Organics Limited | ₹31.11 | — | 49 |
| Biofil Chemicals & Pharmaceuticals Limited | ₹30.18 | 122.8x | 49 |
| Vasundhara Rasayans Ltd | — | 7.8x | 44 |
| Natco Pharma Limited-RE | ₹25.85 | — | 44 |
| Bharat Immunological & Biological Corporation Ltd | — | -3.6x | 43 |
| Kabra Drugs Ltd | — | 6.3x | 41 |
| Medicamen Organics Limited | ₹26.75 | -9.3x | 40 |
| Vista Pharmaceuticals Ltd | — | -2.9x | 39 |
| Parmax Pharma Ltd | — | -40.7x | 38 |
| Rajnish Wellness Ltd | — | -7.8x | 38 |
Natco Pharma Limited-RE versus its peers
Natco Pharma Limited-RE operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of — may be cheap in one industry and expensive in another.
More on Natco Pharma Limited-RE
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.